AVITA Medical Inc’s recently made public that its CFO O’Toole David D acquired Company’s shares for reported $21738.0 on Feb 28 ’24. In the deal valued at $17.39 per share,1,250 shares were bought. As a result of this transaction, O’Toole David D now holds 18,734 shares worth roughly $0.16 million.
Then, CORBETT JAMES sold 1,445 shares, generating $19,204 in total proceeds. Upon selling the shares at $13.29, the CEO now owns 11,580 shares.
Before that, COOK JEREMY CURNOCK sold 2,518 shares. AVITA Medical Inc shares valued at $30,896 were divested by the Director at a price of $12.27 per share. As a result of the transaction, COOK JEREMY CURNOCK now holds 20,596 shares, worth roughly $0.18 million.
BTIG Research downgraded its AVITA Medical Inc [RCEL] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including Cantor Fitzgerald’s analysts, who began to cover the stock in late June with a ‘”an Overweight”‘ rating. Piper Sandler began covering RCEL with “an Overweight” recommendation on March 02, 2021. BofA Securities started covering the stock on August 27, 2020. It rated RCEL as “a Buy”.
Price Performance Review of RCEL
On Monday, AVITA Medical Inc [NASDAQ:RCEL] saw its stock fall -1.04% to $8.55. Over the last five days, the stock has lost -9.62%. AVITA Medical Inc shares have fallen nearly -37.68% since the year began. Nevertheless, the stocks have fallen -40.29% over the past one year. While a 52-week high of $21.70 was reached on 02/27/24, a 52-week low of $8.50 was recorded on 04/22/24. SMA at 50 days reached $15.45, while 200 days put it at $14.62. A total of 0.55 million shares were traded, compared to the trading of 0.39 million shares in the previous session.
Levels Of Support And Resistance For RCEL Stock
The 24-hour chart illustrates a support level at 8.34, which if violated will result in even more drops to 8.13. On the upside, there is a resistance level at 8.88. A further resistance level may holdings at 9.21. The Relative Strength Index (RSI) on the 14-day chart is 15.22, which indicates oversold technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at -3.10, which suggests price will go down in the next trading period. Percent R suggests that price movement has been bearish at 98.75%. Stochastics %K at 1.48% indicates the stock is a buying.
The most recent change occurred on April 21, 2020 when Oppenheimer began covering the stock and recommended ‘”an Outperform”‘ rating along with a $9 price target.
